miRNA Regulation Network Analysis in Qianliening Capsule Treatment of Benign Prostatic Hyperplasia

Objective. The objective of this study was to evaluate the molecular mechanism by which Qianliening capsule (QC) treats benign prostatic hyperplasia (BPH). Methods. Benign prostatic hyperplasia epithelial cell line BPH-1 was treated with 0, 1.25, 2.5, and 5 mg/mL QC for 48 h, respectively. Evaluatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Liya, Wan, Yun, Shen, Aling, Zhao, Jinyan, Lin, Jiumao, Zhong, Xiaoyong, Zhang, Yuchen, Hong, Zhenfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534592/
https://www.ncbi.nlm.nih.gov/pubmed/26294924
http://dx.doi.org/10.1155/2015/365484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534592/
https://www.ncbi.nlm.nih.gov/pubmed/26294924
http://dx.doi.org/10.1155/2015/365484

Ejemplares similares